Home  »  Finance   »  Global Cord Blood Corporation (CO) 2022 Stock Fore...

Global Cord Blood Corporation (CO) 2022 Stock Forecast: Bullish Outlook with 86.33% Upside

Global Cord Blood Corporation (NYSE: CO) is -51.07% lower on its value in year-to-date trading and has touched a low of $2.10 and a high of $5.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CO stock was last observed hovering at around $2.28 in the last trading session, with the day’s loss setting it -0.23% off its average median price target of $15.00 for the next 12 months. It is also 86.33% off the consensus price target high of $15.00 offered by 1 analysts, but current levels are 86.33% higher than the price target low of $15.00 for the same period.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Currently trading at $2.05, the stock is -20.47% and -26.60% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.25 million and changing -10.09% at the moment leaves the stock -44.19% off its SMA200. CO registered -59.16% loss for a year compared to 6-month loss of -48.75%. The firm has a 50-day simple moving average (SMA 50) of -$0.55 and a 200-day simple moving average (SMA200) of -$1.13.

The stock witnessed a -31.67% gain in the last 1 month and extending the period to 3 months gives it a -16.33%, and is -14.23% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.40% over the week and 6.87% over the month.

Global Cord Blood Corporation (CO) has around 1215 employees, a market worth around $280.11M and $184.30M in sales. Current P/E ratio is 3.36. Profit margin for the company is 40.30%. Distance from 52-week low is -2.38% and -62.73% from its 52-week high. The company has generated returns on investments over the last 12 months (10.10%).

Global Cord Blood Corporation (CO) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for Global Cord Blood Corporation (CO) is a “Buy”. 1 analysts offering their recommendations for the stock, where 0 rate it as a Hold and 0 think it is a “Overweight”. 1 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

Global Cord Blood Corporation is expected to release its quarterly report on 11/29/2022.The EPS is expected to shrink by -1.50% this year.

Global Cord Blood Corporation (CO) Top Institutional Holders

The shares outstanding are 121.76M, and float is at 44.88M with Short Float at 0.51%.

Global Cord Blood Corporation (CO) Insider Activity

A total of 0 insider transactions have happened at Global Cord Blood Corporation (CO) in the last six months, with sales accounting for 0 and purchases happening 0 times.

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.